Clinical Trial Update: Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Imiquimod 5% cream for periocular basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: University of Sao Paulo | Conditions: Carcinoma, Basal Cell | Phase 4 | Status: UNKNOWN